Trophoblast stem cells (TSCs) are a heterogeneous cell population despite the presence of fibroblast growth factor (FGF) and transforming growth factor β (TGFB) as key growth factors in standard culture conditions. To understand what other signaling cascades control the stem cell state of mouse TSCs, we performed a kinase inhibitor screen and identified several novel pathways that cause TSC differentiation. Surprisingly, inhibition of phosphoinositide-3-kinase (PI3K) signaling increased the mRNA and protein expression of stem cell markers instead, and resulted in a tighter epithelial colony morphology and fewer differentiated cells. PI3K inhibition could not substitute for FGF or TGFB and did not affect phosphorylation of extracellular signal-regulated kinase, and thus acts independently of these pathways. Upon removal of PI3K inhibition, TSC transcription factor levels reverted to normal TSC levels, indicating that murine TSCs can reversibly switch between these two states. In summary, PI3K inhibition reduces the heterogeneity and seemingly heightens the stem cell state of TSCs as indicated by the simultaneous upregulation of multiple key marker genes and cell morphology. STEM CELLS 2019;37:1307-1318
SIGNIFICANCE STATEMENTTrophoblast stem cells (TSCs) are crucial to the development of a healthy placenta. However, not much is known about the signaling pathways that sustain their self-renewal and drive differentiation. This study uses a kinase inhibitor screen to identify novel pathways that regulate TSCs. Specifically, the authors identified that inhibition of phosphoinositide-3-kinase (PI3K) signaling increases the expression of stem cell markers in these cells. This is in contrast to other cell types, where PI3K inhibition leads to differentiation and apoptosis. The data suggest that just like embryonic stem cells, TSCs exhibit a dynamic stem cell state.